Source/Disclosures
Source:
Schuster N, et al. Vaporized cannabis for the acute treatment of migraine. Presented at: American Headache Society Annual Scientific Meeting; June 15-18, 2023; Austin, Texas.
Disclosures:
Schuster reports consulting for Averitas, Eli Lilly & Co., Schedule 1 Therapeutics, ShiraTronics, Syneos and Vectural Fertin; and receiving research funding from Migraine Research Foundation, NIH CTSA Grant UL1TR000100, Novaremed, and UCSD Academic Senate and Department of Anesthesiology RAG. Please see the study for all other authors’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
